These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25228882)

  • 1. Immune system of the inner ear as a novel therapeutic target for sensorineural hearing loss.
    Okano T
    Front Pharmacol; 2014; 5():205. PubMed ID: 25228882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss.
    Li L; Chao T; Brant J; O'Malley B; Tsourkas A; Li D
    Adv Drug Deliv Rev; 2017 Jan; 108():2-12. PubMed ID: 26796230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed tomography demonstrates abnormalities of contralateral ear in subjects with unilateral sensorineural hearing loss.
    Marcus S; Whitlow CT; Koonce J; Zapadka ME; Chen MY; Williams DW; Lewis M; Evans AK
    Int J Pediatr Otorhinolaryngol; 2014 Feb; 78(2):268-71. PubMed ID: 24359976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inner ear and retrocochlear pathology on magnetic resonance imaging for sudden and progressive asymmetrical sensorineural hearing loss.
    Baird SM; Nguyen K; Bhatia DDS; Wei BPC
    ANZ J Surg; 2019 Jun; 89(6):738-742. PubMed ID: 30497101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of pediatric sensorineural hearing loss with magnetic resonance imaging.
    McClay JE; Booth TN; Parry DA; Johnson R; Roland P
    Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):945-52. PubMed ID: 18794439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune inner ear disease (AIED): A diagnostic challenge.
    Ciorba A; Corazzi V; Bianchini C; Aimoni C; Pelucchi S; Skarżyński PH; Hatzopoulos S
    Int J Immunopathol Pharmacol; 2018; 32():2058738418808680. PubMed ID: 30376736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. l-Thyroxine does not prevent immunemediated sensorineural hearing loss in autoimmune thyroid diseases.
    Rodríguez-Valiente A; Álvarez-Montero Ó; Górriz-Gil C; García-Berrocal JR
    Acta Otorrinolaringol Esp (Engl Ed); 2019; 70(4):229-234. PubMed ID: 30107874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Update on physiology and pathophysiology of the inner ear: pathomechanisms of sensorineural hearing loss].
    Strenzke N; Pauli-Magnus D; Meyer A; Brandt A; Maier H; Moser T
    HNO; 2008 Jan; 56(1):27-36. PubMed ID: 18210004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune inner ear disease.
    Ruckenstein MJ
    Curr Opin Otolaryngol Head Neck Surg; 2004 Oct; 12(5):426-30. PubMed ID: 15377956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Constitute, imaging and auditory characteristics of pediatric patients with congenital malformations of inner ear in sensorineural hearing loss].
    Li Y; Yang J; Li Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan; 25(1):1-5. PubMed ID: 21469382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune inner ear disease--a real entity?
    Barna BP; Hughes GB
    Clin Lab Med; 1997 Sep; 17(3):581-94. PubMed ID: 9316775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of evidence for autoimmune pathology of bilateral sudden sensorineural hearing loss using proteomic analysis.
    Lee JM; Kim JY; Bok J; Kim KS; Choi JY; Kim SH
    Clin Immunol; 2017 Oct; 183():24-35. PubMed ID: 28648633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tinnitus and Mild Hearing Loss From a Kiss.
    Goyal L; Ajmera K; Kaasam S; Koppula K
    Cureus; 2022 May; 14(5):e24955. PubMed ID: 35706728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-based drug delivery in the inner ear: current challenges, limitations and opportunities.
    Mittal R; Pena SA; Zhu A; Eshraghi N; Fesharaki A; Horesh EJ; Mittal J; Eshraghi AA
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1312-1320. PubMed ID: 30987439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Platelet-Rich Plasma in the Management of Sensorineural Hearing Loss: Current Evidence and Emerging Trends.
    Singh CV; Jain S
    Cureus; 2024 Sep; 16(9):e68646. PubMed ID: 39371823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hearing loss in autoimmune disorders: Prevalence and therapeutic options.
    Mancini P; Atturo F; Di Mario A; Portanova G; Ralli M; De Virgilio A; de Vincentiis M; Greco A
    Autoimmun Rev; 2018 Jul; 17(7):644-652. PubMed ID: 29729446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deafness-in-a-dish: modeling hereditary deafness with inner ear organoids.
    Romano DR; Hashino E; Nelson RF
    Hum Genet; 2022 Apr; 141(3-4):347-362. PubMed ID: 34342719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental animal models of drug-induced sensorineural hearing loss: a narrative review.
    Lin X; Luo J; Tan J; Yang L; Wang M; Li P
    Ann Transl Med; 2021 Sep; 9(17):1393. PubMed ID: 34733945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal CT findings are risk factors for otitis media-related sensorineural hearing loss.
    Yang CJ; Kim TS; Shim BS; Ahn JH; Chung JW; Yoon TH; Park HJ
    Ear Hear; 2014; 35(3):375-8. PubMed ID: 24499975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-related immune responses in inner ear: a potential therapeutic target for sensorineural hearing loss.
    Liu YC; Xu K
    Front Neurosci; 2023; 17():1339134. PubMed ID: 38274500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.